NeuroPace (NASDAQ:NPCE) Coverage Initiated at HC Wainwright
Stock analysts at HC Wainwright began coverage on shares of NeuroPace (NASDAQ:NPCE – Get Free Report) in a note issued to investors on Wednesday, MarketBeat reports. The firm set a “buy” rating and a $18.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 37.30% from the company’s previous […]
Stock analysts at HC Wainwright began coverage on shares of NeuroPace (NASDAQ:NPCE – Get Free Report) in a note issued to investors on Wednesday, MarketBeat reports. The firm set a “buy” rating and a $18.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 37.30% from the company’s previous […]
